Boncore withdraws pharma-friendly budget amendment

Senate disagreement over drug pricing looming with House

WITH A PHARMA-FRIENDLY amendment withdrawn from consideration, the Senate is on track to stick with its more hardline approach toward MassHealth drug pricing in the fiscal 2020 budget. That would set up a big disagreement with the House, which amended the drug-pricing approach in its budget bill by plugging in language that was welcomed by(...)

Read More »